A104540 Share Price Performance
Recent A104540 News & Updates
No updates
Corentec Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 32.86
- Gross Margin
- 52.19%
- Net Profit Margin
- 0.43%
- Debt/Equity Ratio
- 59.0%
Corentec Co., Ltd. Competitors
About A104540
- Founded
- 2000
- Employees
- 171
- CEO
- WebsiteView website
Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems, such as Lospa IS systems; Coralis shoulder systems; and trauma systems, including LCfit HTO plate systems and Optirad volar plate system. Corentec Co., Ltd. was founded in 2000 and is headquartered in Cheonan-si, South Korea.
South Korean Market Performance
- 7 Days: -2.5%
- 3 Months: 19.7%
- 1 Year: 13.3%
- Year to Date: 27.4%
Over the last 7 days, the market has dropped 2.5%, driven by a pullback of 8.3% in the Financials sector. As for the longer term, the market has actually risen by 13% in the last year. Looking forward, earnings are forecast to grow by 22% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading